| Theme | Autoimmune Pancreatitis -- Present Status & Future Perspectives | |
|---|---|---|
| Title | Diagnostic Criteria for Autoimmune Pancreatitis | |
| Publish Date | 2018/02 | |
| Author | Terumi Kamisawa | Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital |
| Author | Sawako Kuruma | Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital |
| Author | Kazuro Chiba | Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital |
| Author | Taku Tabata | Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital |
| Author | Satomi Koizumi | Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital |
| Author | Masataka Kikuyama | Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital |
| [ Summary ] | Autoimmune pancreatitis (AIP) is diagnosed using a combination of several discriminative features. It is most important to differentiate it from pancreatic cancer. The international consensus diagnostic criteria (ICDC) for AIP, which diagnose type 1 AIP related with IgG4 (lymphoplasmacytic sclerosing pancreatitis ; LPSP) and type 2 AIP (idiopathic duct‒centric pancreatitis ; IDCP) separately. ICDC used 5 cardinal features of AIP (imaging of pancreatic parenchyma and duct, serology, other organ involvement, pancreatic histology, and an optional criterion of response to steroid therapy). In line with the ICDC, the Japanese clinical diagnostic criteria for type 1 AIP were revised in 2011. | |